Skip to main content

COVID-19 Resources

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.cdc.gov/coronavirus

Get the latest research information from NIH: https://www.covid19.nih.gov

Grant Details

Grant Number: 3R01CA237322-03S2 Interpret this number
Primary Investigator: Henrikson, Nora
Organization: Kaiser Foundation Research Institute
Project Title: Legacy Project - Diversity Supplement
Fiscal Year: 2021


Abstract

Project Summary: Legacy – what one leaves behind and how one hopes to be remembered after death— is an important part of the human experience. In the parent grant, our related preliminary work, we have encountered multiple anecdotal reports from people considering their legacy as they make cancer treatment choices, suggesting that legacy has a clear financial component and is relevant to understanding cancer-related financial hardship. However, very limited research exists about legacy planning as it relates to cancer care. Deeper understanding of the legacy construct and how it relates to cancer-related financial hardship and treatment choices could guide how to incorporate legacy considerations into financial navigation interventions like the one in the parent grant. This supplemental study will examine how people with cancer consider legacy, both in general and when making medical decisions, with focus on the financial aspects of legacy. Through a critical literature review and semi-structured interviews with cancer patients and their families, this study will build a conceptual model and preliminary data that will inform a future R01-level (or equivalent) research grant proposal led by Dr. Marlaine Figueroa Gray, junior faculty member, first generation college graduate, and member of an underrepresented minority group, at Kaiser Permanente Washington Health Research Institute.



Publications


None. See parent grant details.


Back to Top